Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ucb ADR (UCBJY)

Ucb ADR (UCBJY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ucb ADR Allee de la Recherche 60 Brussels C9 1070 BEL

www.ucb.com Employees: 9,083 P: 32-2559-9999

Description:

UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease. It also provides therapy in the areas of oncology, immunology, inflammation, allergy and respiratory diseases. UCB delivers small and large molecule solutions to specialists for use in the treatment of severe diseases.

Key Statistics

Overview:

Market Capitalization, $K 35,437,472
Enterprise Value, $K 37,793,644
Shares Outstanding, K 378,040
Annual Sales, $ 5,684 M
Annual Net Income, $ 371,230 K
EBIT, $ 0 K
EBITDA, $ 1,332 M
60-Month Beta 0.46
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Volume Ratio 0.56

Growth:

1-Year Return 151.99%
3-Year Return 68.60%
5-Year Return 133.49%
5-Year Revenue Growth 3.91%
5-Year Earnings Growth -18.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.663 on 05/02/13
Dividend Payable Date 05/20/14
Dividend Payout Ratio 0.00%

UCBJY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 35.27
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 6.53%
Debt/Equity 0.34
Price/Sales N/A
Price/Cash Flow 23.07
Price/Book 3.61
Book Value/Share 0.00
Interest Coverage 3.10

UCBJY Dividends

Date Value
05/02/13 $0.6630
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar